Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Liabilities and Shareholders Equity (2020 - 2025)

Maravai Lifesciences Holdings (MRVI) has 6 years of Liabilities and Shareholders Equity data on record, last reported at $770.6 million in Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 23.57% year-over-year to $770.6 million; the TTM value through Dec 2025 reached $3.5 billion, down 32.82%, while the annual FY2025 figure was $770.6 million, 23.57% down from the prior year.
  • Liabilities and Shareholders Equity reached $770.6 million in Q4 2025 per MRVI's latest filing, down from $849.2 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $2.3 billion in Q1 2023 and bottomed at $770.6 million in Q4 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $1.6 billion, with a median of $1.5 billion recorded in 2021.
  • Peak YoY movement for Liabilities and Shareholders Equity: surged 51.15% in 2022, then plummeted 43.63% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.9 billion in 2021, then grew by 18.98% to $2.3 billion in 2022, then crashed by 34.83% to $1.5 billion in 2023, then tumbled by 32.22% to $1.0 billion in 2024, then dropped by 23.57% to $770.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $770.6 million in Q4 2025, $849.2 million in Q3 2025, and $897.0 million in Q2 2025.